Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) FCF Margin: 2024-2025

Historic FCF Margin for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -400.93%.

  • Kura Oncology's FCF Margin fell 1094462.00% to -400.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 167.08%, marking a year-over-year change of. This contributed to the annual value of 248.40% for FY2024, which is 782081.00% down from last year.
  • As of Q3 2025, Kura Oncology's FCF Margin stood at -400.93%, which was down 102.73% from -197.77% recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's FCF Margin peaked at 12,293.47% during Q1 2024, and registered a low of -66,689.58% during Q4 2024.
  • Over the past 2 years, Kura Oncology's median FCF Margin value was -197.77% (recorded in 2025), while the average stood at -4,926.25%.
  • Data for Kura Oncology's FCF Margin shows a maximum YoY tumbled of 1,280,537bps (in 2025) over the last 5 years.
  • Kura Oncology's FCF Margin (Quarterly) stood at -66,689.58% in 2024, then tumbled by 1,094,462bps to -400.93% in 2025.
  • Its last three reported values are -400.93% in Q3 2025, -197.77% for Q2 2025, and -511.90% during Q1 2025.